These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26324722)

  • 1. Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex.
    Shinsky SA; Cosgrove MS
    J Biol Chem; 2015 Oct; 290(43):25819-33. PubMed ID: 26324722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.
    Alicea-Velázquez NL; Shinsky SA; Loh DM; Lee JH; Skalnik DG; Cosgrove MS
    J Biol Chem; 2016 Oct; 291(43):22357-22372. PubMed ID: 27563068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.
    Shinsky SA; Monteith KE; Viggiano S; Cosgrove MS
    J Biol Chem; 2015 Mar; 290(10):6361-75. PubMed ID: 25561738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
    Dharmarajan V; Lee JH; Patel A; Skalnik DG; Cosgrove MS
    J Biol Chem; 2012 Aug; 287(33):27275-89. PubMed ID: 22665483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.
    Shinsky SA; Hu M; Vought VE; Ng SB; Bamshad MJ; Shendure J; Cosgrove MS
    J Mol Biol; 2014 Jun; 426(12):2283-99. PubMed ID: 24680668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel non-SET domain multi-subunit methyltransferase required for sequential nucleosomal histone H3 methylation by the mixed lineage leukemia protein-1 (MLL1) core complex.
    Patel A; Vought VE; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2011 Feb; 286(5):3359-69. PubMed ID: 21106533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of nucleosome recognition and modification by MLL methyltransferases.
    Xue H; Yao T; Cao M; Zhu G; Li Y; Yuan G; Chen Y; Lei M; Huang J
    Nature; 2019 Sep; 573(7774):445-449. PubMed ID: 31485071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain.
    Cao F; Chen Y; Cierpicki T; Liu Y; Basrur V; Lei M; Dou Y
    PLoS One; 2010 Nov; 5(11):e14102. PubMed ID: 21124902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conserved arginine-containing motif crucial for the assembly and enzymatic activity of the mixed lineage leukemia protein-1 core complex.
    Patel A; Vought VE; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2008 Nov; 283(47):32162-75. PubMed ID: 18829457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.
    Patel A; Dharmarajan V; Vought VE; Cosgrove MS
    J Biol Chem; 2009 Sep; 284(36):24242-56. PubMed ID: 19556245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WRAD: enabler of the SET1-family of H3K4 methyltransferases.
    Ernst P; Vakoc CR
    Brief Funct Genomics; 2012 May; 11(3):217-26. PubMed ID: 22652693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation.
    Patel A; Vought VE; Swatkoski S; Viggiano S; Howard B; Dharmarajan V; Monteith KE; Kupakuwana G; Namitz KE; Shinsky SA; Cotter RJ; Cosgrove MS
    J Biol Chem; 2014 Jan; 289(2):868-84. PubMed ID: 24235145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.
    Zhang P; Lee H; Brunzelle JS; Couture JF
    Nucleic Acids Res; 2012 May; 40(9):4237-46. PubMed ID: 22266653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide.
    Patel A; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2008 Nov; 283(47):32158-61. PubMed ID: 18829459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.
    Cho YW; Hong T; Hong S; Guo H; Yu H; Kim D; Guszczynski T; Dressler GR; Copeland TD; Kalkum M; Ge K
    J Biol Chem; 2007 Jul; 282(28):20395-406. PubMed ID: 17500065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse roles of WDR5-RbBP5-ASH2L-DPY30 (WRAD) complex in the functions of the SET1 histone methyltransferase family.
    Ali A; Tyagi S
    J Biosci; 2017 Mar; 42(1):155-159. PubMed ID: 28229975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction.
    Karatas H; Townsend EC; Bernard D; Dou Y; Wang S
    J Med Chem; 2010 Jul; 53(14):5179-85. PubMed ID: 20575550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of MLL1 H3K4 methyltransferase activity by its core components.
    Dou Y; Milne TA; Ruthenburg AJ; Lee S; Lee JW; Verdine GL; Allis CD; Roeder RG
    Nat Struct Mol Biol; 2006 Aug; 13(8):713-9. PubMed ID: 16878130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein- Protein Interaction.
    Ye X; Chen G; Jin J; Zhang B; Wang Y; Cai Z; Ye F
    Curr Med Chem; 2020; 27(33):5530-5542. PubMed ID: 31132972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex.
    Weirich S; Kudithipudi S; Jeltsch A
    Mol Oncol; 2017 Apr; 11(4):373-387. PubMed ID: 28182322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.